Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Baseline Visual Function and Inflammatory Markers in the RP PRIMARY Study
Author Affiliations & Notes
  • Takahiro Hisai
    Kyushu Daigaku, Fukuoka, Fukuoka, Japan
  • Sakurako Shimokawa
    Kyushu Daigaku, Fukuoka, Fukuoka, Japan
  • Masatoshi Fukushima
    Kyushu Daigaku, Fukuoka, Fukuoka, Japan
  • Kohta Fujiwara
    Kyushu Daigaku, Fukuoka, Fukuoka, Japan
  • Akie Hirata
    Kyushu University, Medical Information Center, Japan
  • Atsushi Takada
    Kyushu University, Medical Information Center, Japan
  • Yuko Kobayakawa
    Kyushu University, Center for Clinical and Translational Research, Japan
  • Go Mawatari
    Miyazaki Daigaku, Miyazaki, Miyazaki, Japan
  • Masataka Ishizu
    Miyazaki Daigaku, Miyazaki, Miyazaki, Japan
  • Tomoko Kaida
    Miyata Ganka Byoin, Miyakonojo, Miyazaki, Japan
  • Kazunori Miyata
    Miyata Ganka Byoin, Miyakonojo, Miyazaki, Japan
  • Yasuhiro Ikeda
    Miyazaki Daigaku, Miyazaki, Miyazaki, Japan
  • Koh-Hei Sonoda
    Kyushu Daigaku, Fukuoka, Fukuoka, Japan
  • Yusuke Murakami
    Kyushu Daigaku, Fukuoka, Fukuoka, Japan
  • Footnotes
    Commercial Relationships   Takahiro Hisai None; Sakurako Shimokawa None; Masatoshi Fukushima None; Kohta Fujiwara None; Akie Hirata None; Atsushi Takada None; Yuko Kobayakawa None; Go Mawatari None; Masataka Ishizu None; Tomoko Kaida None; Kazunori Miyata None; Yasuhiro Ikeda None; Koh-Hei Sonoda None; Yusuke Murakami None
  • Footnotes
    Support  The Japan Agency for Medical Research and Development, Practical Research Project for Rare/Intractable Diseases, #JP23ek0109512h0003
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3098. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Takahiro Hisai, Sakurako Shimokawa, Masatoshi Fukushima, Kohta Fujiwara, Akie Hirata, Atsushi Takada, Yuko Kobayakawa, Go Mawatari, Masataka Ishizu, Tomoko Kaida, Kazunori Miyata, Yasuhiro Ikeda, Koh-Hei Sonoda, Yusuke Murakami; Baseline Visual Function and Inflammatory Markers in the RP PRIMARY Study. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3098.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To analyze the association between visual function and inflammatory markers in the baseline data of prospective observational study of patients with typical retinitis pigmentosa (RP Progression and Inflammatory Marker Registry Study: The RP PRIMARY Study).

Methods : Sixty-seven patients with typical RP in Kyushu University Hospital, University of Miyazaki Hospital and Miyata Eye Hospital who agreed to participate in this study and met the inclusion criteria were included between October 2021 and October 2022. Baseline examinations included ETDRS visual acuity, Humphrey Field Analyzer (HFA) 10-2 program (mean deviation (MD) value and the average sensitivity of 4 and 12 central points), ellipsoid zone (EZ) length and autofluorescence (AF) ring area as visual function, and aqueous flare and blood tests (e.g. hs-CRP, white blood cell (WBC) fraction) as inflammatory markers. The correlation between visual function and inflammatory markers were analyzed by Spearman's rank correlation coefficient.

Results : The mean age of participants was 50.7 ± 11.8 years. Correlation analyses demonstrated that aqueous flare values were negatively correlated with ETDRS visual acuity (ρ=-0.30, p=0.013), EZ length (ρ=-0.26, p=0.033), AF ring area (ρ=-0.31, p=0.013), and the average sensitivity of 4 central points in HFA 10-2 (ρ=-0.32, p=0.008). There was no apparent correlation of hs-CRP or WBC fractions with visual function.

Conclusions : In the baseline data of The RP PRIMARY study, aqueous flare, an ocular inflammatory marker, was negatively associated with visual function. The association between these inflammatory markers and disease progression will be evaluated in the ongoing prospective study.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×